SUMMARY A case of acute conjunctivitis in man caused by Chlamydia IOL 207 is described.
Chlamydia trachomatis causes a range' of ocular diseases in man from trachoma in developing countries to sexually transmitted, oculogenital infections in developed countries. Infections by Chlamydia psittaci are usually confined to the animal kingdom, although sporadic cases of ocular infection in man have been reported. Exposure in the laboratory to C. psittaci agents as well as transmission from cats have been responsible for cases of human conjunctivitis.'2 C. psittaci has also been isolated from a patient with keratitis and uveitis. Here we present a case of acute conjunctivitis in man caused by an atypical chlamydial strain, designated Chlamydia IOL 207. Serological evidence indicates that infection with this agent is common in some communities.45 However, the site and natural history of these infections are unknown.
Case report
The patient was a 30-year-old male laboratory technician who was routinely handling chlamydial agents. He coinplained of redness, swelling of the right eye,.and discharge for 2 days before attending the clinic. On examination a moderate degree of hyperaemia was seen in the bulbar conjunctiva, and moderate hyperaemia and papillary and follicular responses were observed in the palpebral conjunctiva of the right eye, the left eye being normal. A tentative diagnosis of a viral conjunctivitis was made. After collection of conjunctival swabs, blood, and tears, the patient was treated with 1% trifluorothymidine drops. One week later, 9 days from onset, the patient had developed a mild rhinitis, and symptoms in the right eye had worsened. The intensity of papillary and follicular reactions in the palpebral conjunctivae of the upper and lower lids was more severe (Figs. 1,  2, 3) . No abnormalities were detected in the cornea. At this stage a clinical diagnosis of chlamydial conjunctivitis was made, and the patient was treated with systemic doxycycline (at an initial dose of 300 mg followed by 100 mg daily for 3 weeks) and topical aureomycin (5 times daily for 6 weeks). Three days later, 12 days from onset, the signs and symptoms in the right eye had improved. During the course of infection in the right eye a mild inflammatory response was observed in the left eye. Seventeen weeks after onset the patient was asymptomatic. The intensity of clinical signs observed during the course of the disease is shown in Fig. 4 . Conjunctival swabs were collected from the right eye at 2 days and at 7 days from onset. Attempts to isolate chlamydiae in McCoy cells' and viruses in tissue cultures7 were unsuccessful even after several passages. However, chlamydiae were isolated in the yolk sac of fertile hens' eggs' from both sets of specimens. These chlamydial isolates could not be propagated continuously in yolk sac nor transferred to tissue culture. Consequently these isolates were not serotyped.
Serum and tears were collected during the course of the infection and tested against a range of chlamydial serotypes in a microimmunofluorescence test.9 Also tested was a sample of serum collected from this patient 2 years previously. Type-specific IgG antbodies to C. IOL 207 were detected at a titre of 1/16 in the preinfection serum sample. The level of these serum antibodies rose to 1/512 during the infection and dropped back to 1/16 after 6 months (Fig. 5) . No IgM antibodies were detected.
In tears collected from the right eye type-specific IgG and IgA antibodies to C. IOL 207 appeared at 7 days from onset of disease and rose to titres of 1/128 and 1/64 respectively (Fig. 5) . The titres of these antibodies were closely related to the intensity of clinical signs in the right eye (Figs. 4, 5) . IgA disappeared after treatment when the signs became mild at 7 weeks from onset. IgG disappeared from the tears when the patient became asymptomatic at 17 weeks from onset. No antibodies were detected in tears collected from the left eye.
No antibodies were detected against C. trachomatis or C. psittaci serotypes in serum or tears. 13 In that study tissue culture proved not to be sensitive for the reisolation of C. IOL 207, and the agent was reisolated only after several passages in the yolk sac of fertile eggs. In London antibodies to this agent have been detected in patients with oculogenital infections4 as well as in large numbers of male and female 'healthy' blood donors.5 We have also found that antibodies to C. IOL 207 are uncomlihon in children under the age of 5 but increase in prevalence after that age (unpublished observations). Our seroepidemiological surveys have also shown that infection by C. IOL 207 is common among populations in Africa and the Middle East (unpublished observations).
This case report demonstrates that Chlamydia IOL 207 is a human pathogen capable of causing acute conjunctivitis. Serological evidence suggests that infections with this organism are widespread in some communities. However, the lack of isolation data means that the epidemiology and natural history of these infections is still unknown. We believe that further work is needed to elucidate the role of C. IOL 207 in diseases of the eye and other organs.
